AIDS Weekly articles from January 2004

AIDS Weekly archives from January 2004

Growth hormone treatment can improve NK-cell function.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Growth hormone therapy can improve NK-cell function in HIV patients. "Previous studies have shown that human natural killer (NK) cells are lost from the periphery and are functionally suppressed...

Small-molecule CCR5 inhibitor effective in macaques.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- A small-molecule CCR5 inhibitor significantly reduces viremia in macaques infected with the simian version of HIV. "Human immunodeficiency virus type 1 (HIV-1) fuses with cells after sequential...

Markovian model can aid anti-HIV drug design.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- A novel Markovian model may aid the design of antiretroviral agents. "The design of novel anti-HIV compounds has now become a crucial area for scientists working in numerous interrelated fields of...

Novel computational approach aids HIV protease inhibitor design.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- A novel design method may improve the development of HIV protease inhibitors. In a recent study, scientists in Belgium "developed a computational approach in which an inhibitor's strength is...

Thymosin alpha1 shows promise for improving immune recovery.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Thymosin alpha1 appears to improve immune recovery in HIV patients. According to published research from Singapore, "To study the safety and efficacy of thymosin alpha1 in stimulating immune...

AIDS therapy less risky than assumed.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The immune deficiency syndrome AIDS can by now be treated successfully with effective drug cocktails. Unfortunately, however, these involve the risk of dangerous side effects, as the drugs employed in...

Nearly 6000 AIDS deaths in Malaysia since 1985.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Malaysia has recorded 5934 AIDS deaths since the disease was first reported there 18 years ago, a health official says. The deaths were from a total of 56,667 HIV infections and 8027 AIDS cases...

Company issues statement on antiretroviral treatment study.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline issued the following statement: We welcome the publication in the December 11 [2003] issue of New England Journal of Medicine of the results of ACTG384, a study comparing anti-HIV...

Life priorities of HIV-seropositive injection drug users revealed.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Findings from a community-based sample reveal the life priorities of HIV-seropositive injection drug users. According to recent research published in the journal AIDS and Behavior, "Using...

National Blood Service in England begins nucleic acid testing.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) announced that the National Blood Service in England has begun nucleic acid testing (NAT) at its Brentwood site with the company's Procleix HIV-1/HCV Assay. The assay is...

Topical tacrolimus effective against CAD with idiopathic leukopenia.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Topical tacrolimus therapy can ameliorate the symptoms of chronic active dermatitis (CAD). CAD "is a photosensitivity disorder marked by severe eczematous lesions on exposed areas," dermatologists...

Company initiates feasibility study with Acertus of RapidMist system.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) has entered into an agreement with Acertus Pharma, Ltd., to evaluate the feasibility of developing a prototype drug-delivery system using Generex's RapidMist...

Antiviral pronucleotides improved through cycloSal system.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The cycloSal system can be used to improve the efficacy of antiviral pronucleotide agents. "Pronucleotides represent a promising alternative to improve the biological activity of nucleoside analogs...

HIV RNase H activity characterization leads to novel anti-HIV agents.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The activity of HIV RNase H has been elucidated, and this information has been used to develop novel anti-HIV agents "Human immunodeficiency virus (HIV) RNase H activity is essential for the...

NIH begins human Ebola vaccine trial using Biojector 2000.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Bioject Medical Technologies, Inc., (BJCT), a developer of needle-free drug delivery systems, announced that the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious...

Lentiviral vectors efficiently transduce HLECs.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Lentiviral vectors can efficiently deliver therapeutic genes to cultured HLECs. "Endothelial cells play multiple roles in pathophysiologic processes and are increasingly being recognized as target...

Advantages of rectal vaccination against HIV described.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- AIDS immunization is still to be improved. Russian scientists suggest that rectal vaccination could be the most effective prevention of HIV transmission. The work is supported by the Interdepartmental...

Recombinant DNA model enables HIV-2 gene analysis.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- A recombinant DNA model enables extensive genetic analysis of HIV-2. "Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) differ in their pathogenic mechanisms as evidenced by lower rate...

"Mega-PCR" assay lowers detection limit of HIV DNA.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- A novel "mega-PCR" assay can find previously undetectable levels of HIV DNA in blood samples. In a recent study from Switzerland, "An internally controlled high-input PCR method, termed HIV-1...

FIV induces phenotypical changes in CD8 cells.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The feline version of HIV induces phenotypical changes in CD8 - but not CD4 - cells. "It is well documented that several cell surface molecules of T lymphocytes are altered by immune activation,"...

Low HDMT scores may not indicate HIV neurodegeneration.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Low HDMT scores do not necessarily indicate HIV neurodegeneration. According to a study from the United States, "There is an emergent need for base rate data on symptom validity tests (SVTs) in...

Pneumocystis carinii mt LSU rRNA gene in SIV-infected macaques examined.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The P. carinii mt LSU rRNA gene has been characterized in SIV-infected monkeys. In a recent study from the United States, "The nucleotide sequences of a segment of the Pneumocystis mitochondrial...

Solid phase cytometry test provides rapid Aspergillus fumigatus detection.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- A novel assay could aid diagnosis of Aspergillus infection in immunocompromised patients. In a recent study from Belgium, "A rapid method based on solid phase cytometry (SPC) for the detection of...

HIV-exposed but uninfected IDUs have heightened NK-cell activity.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Injecting drug users who remain HIV-negative after extensive exposure have elevated levels of natural killer (NK)-cell activity. In a recent study, scientists in France "addressed the role of...

Viral replication does not lead to SIV disease progression in sooty mangabeys.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Surprisingly, viral replication in SIV-infected sooty mangabeys does not lead to disease progression. "Simian immunodeficiency virus SIVsm causes an asymptomatic infection in its natural host, the...

HIV Tat interacts with Notch protein EGF-like repeats and the EGF precursor.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- HIV Tat interacts with Notch protein EGF-like repeats and the EGF precursor. In a recent study from Israel, by "employing the yeast two-hybrid system, the Tat protein of the human immunodeficiency...

Molecular assay enables accurate measure of CCR5 mRNA.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- A novel molecular assay provides a sensitive and accurate measure of CCR5 mRNA. According to published research from the United States, "CCR5, a beta-chemokine receptor, plays an important role in...

Nucleic acid tests increase safety of blood products.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Screening with nucleic acid tests has reduced the risk of HIV infection from blood transfusions or receipt of blood products to a very low level. "In most developed countries of the world, the risk...

Mediators of protease inhibitor-induced bone resorption identified.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The molecular mediators of HIV protease inhibitor-induced bone damage have been identified. "Accelerated bone resorption leading to osteopenia and osteoporosis has been noted in human...

Modified p24 antigen assay useful for disease monitoring in HIV patients.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- A modified p24 antigen assay may simplify disease monitoring in HIV patients. "HIV-1 RNA has become the standard for monitoring antiretroviral therapies," immunologists in Switzerland explained....

Nelfinavir does not cause reproductive toxicity in rats.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The antiretroviral agent nelfinavir does not affect reproductive performance or embryonic development in a murine model of HIV treatment. In a study from the United States, "The potential for...

Prophylactic antiretroviral treatment reduces T-cell apoptosis.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Prophylactic antiretroviral treatment significantly reduces T-cell apoptosis. "It has been proposed that antiretroviral therapies (ART) possess both antiviral and immunomodulatory activities when...

HIV-1 viral load influences risk of mother-to-child HIV transmission.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Researchers list risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in a recent issue of the Journal of Acquired Immune Deficiency Syndromes. "Short-course...

Clinical trials begin for Procleix Ultrio assay.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) and Gen-Probe Incorporated (GPRO) announced that clinical trials of the Procleix Ultrio Assay, for the simultaneous detection of HIV-1, hepatitis C virus (HCV) and hepatitis B...

Company licenses more generic AIDS drug sales in South Africa.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline PLC announced that it will license up to three more South African companies to manufacture generic versions of its AIDS medicines and allow the country to import drugs produced...

DB289 demonstrates potent antimalarial results in human clinical trial.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Immtech International, Inc., (IMM) announced that the company's oral drug candidate, DB289, demonstrated potent antimalarial activity in the human clinical trial conducted in Bangkok, Thailand. The...

AVR118 suppresses progression of disease in animal model.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that administration of its novel immunomodulator AVR118 (formerly known as Product R) in animals with induced experimental allergic encephalomyelitis (EAE)...

Diffusion imaging and proton MRI can aid HSE diagnosis in AIDS patients.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Several magnetic resonance imaging (MRI) techniques are useful for diagnosing HSE in AIDS and other patients. Scientists in Germany described a "case of pathologically proved atypical herpes...

David Arkowitz becomes CFO.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Idenix Pharmaceuticals, Inc., announced the appointment of David Arkowitz to the position of CFO. Arkowitz has more than 13 years of experience in financial leadership positions at Merck & Co,...

AIDS group releases white paper urging new HIV prevention strategies.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- With World AIDS Day observations concluded for another year, AIDS Project Los Angeles (APLA) has announced the publication of "Changing How We Think: HIV Prevention Policy in the U.S.," a white paper...

Canadian university receives US$11.7 million grant from Gates Foundation.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The University of Montreal has announced a commitment of US$11.7 million (CAN$16 million) from the Bill & Melinda Gates Foundation to build capacity for population and health research and policy in...

Calendar encourages African Americans to adopt better health practices.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- Kentucky's Lexington-Fayette County Health Department is encouraging better health practices among its African Americans residents with a calendar that features some health-conscious Kentuckians. ...

Data on next-generation VEGF cancer agent presented at ASH.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The first in the next generation of vascular endothelial growth factor (VEGF) inhibiting agents - those that employ a three-prong approach to inhibiting tumor growth - can be administered safely in a...

Effects of GBV-C co-infection on HIV progression reviewed.
January 5, 2004... 2004 JAN 5 - (NewsRx.com & NewsRx.net) -- The effects of GB virus type C hepatitis G virus (GBV-C) co-infection on HIV progression have been reviewed. GBV-C "is a common virus that does not appear to cause disease," scientists in the...

Methylnaltrexone inhibits opioid-mediated HIV macrophage infection.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Methylnaltrexone inhibits opioid-mediated HIV infection of macrophages. "Opioid abuse has been postulated as a cofactor in the immunopathogenesis of human immunodeficiency virus (HIV) infection and...

Poly(allylamine hydrochloride) disrupts Tat-TAR RNA interaction.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- A novel antiretroviral agent disrupts a key HIV protein-RNA interaction. According to recent research from China, "The interaction of poly(allylamine hydrochloride) (PAH) with TAR RNA has been...

Anti-HIV alkaloids isolated from Monanchora sponge.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Novel antiretroviral compounds have been isolated from sponges. In a recent study from the United States, "Two new polycyclic guanidine alkaloids, crambescidin 826 (1) and dehydrocrambine A (2),...

VIP/NTM peptide mimetics show promise for HIV treatment.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- VIP/NTM peptide mimetics may be useful as anti-HIV immunotherapies. "It has been reported that the C-terminus of the second conserved region (C2) of the envelope glycoprotein gp120, encompassing...

HAART has limited effect on hypertension risk.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Antiretroviral therapy has little or no effect on hypertension risk. "Highly active antiretroviral therapy (HAART) may induce dyslipidemia, insulin resistance and body fat distribution similar to...

Novel HIV viremia model may aid evaluation of drug efficacy.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- A novel model of HIV viremia may aid evaluation of antiretroviral drug efficacy. Scientists in the United States developed "a model of HIV dynamics under antiretroviral therapy that combines drug...

FDA 510(k) clearance granted for the CellTracks Analyzer for HIV/AIDS.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Immunicon Corp. announced that it has received 510(k) clearance for its CellTracks Analyzer for enumeration of CD3 and CD4 lymphocyte subsets. Physicians use these cells as an aid to monitoring...

U.N. envoy says clerics can help prevent spread of AIDS in Pakistan.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- A U.N. expert has urged Pakistani clerics to play a role in preventing HIV/AIDS in the Islamic nation. "So far, only a small number of people have been affected from HIV/AIDS in Pakistan, but the...

Company files additional data with FDA on new Reveal Rapid HIV-1 Antibody Test.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- MedMira, Inc., (MIR) announced that it has successfully completed the clinical requirements set forth by the U.S. Food and Drug Administration (FDA) for a new version of the Reveal Rapid HIV-1 Antibody...

Abbott raises AIDS drug price more than 400%.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories is hiking the U.S. price of an important AIDS drug more than fourfold, citing its sharp increase in treatment value and the costs of improving its formulation. The company...

U.S. officials say interviews for HIV study were fabricated.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- U.S. officials say three former University of Maryland employees fabricated 18 interviews with adolescents as part of a study on HIV risk reduction. All suspect interviews were deleted from the...

Gene identification company reports 73.7% gross profit margin.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Enzo Biochem, Inc., (ENZ), a biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, reported operating...

Additional data submitted to FDA for OraQuick HIV-2 claim.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- OraSure Technologies, Inc., (OSUR) has submitted the additional data requested by the U.S. Food and Drug Administration (FDA) in support of an HIV-2 claim for its OraQuick Rapid HIV-1 Antibody Test....

48-Week data submitted to FDA for full approval of HIV fusion inhibitor.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Roche and Trimeris, Inc., (TRMS) announced submission of 48-week efficacy and safety data from two pivotal studies of Fuzeon to the U.S. Food and Drug Administration (FDA) to support its full, or...

Human foreskin may have a key role in passing on HIV infection.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Human foreskin may have a key role in helping to pass on HIV infection, suggests new research. Previous research suggests that circumcision may protect against the transmission of some viral...

Novel trypanosomatids reported in HIV patients.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Normally benign trypanosomatids can act as pathogens in HIV patients. "Although the family Trypanosomatidae includes parasites of plants, insects and vertebrates, only two genera in the family,...

p38 MAPK mediates negative inotropic effect of gp120 on myocytes.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- HIV gp120 has a negative inotropic effect on cardiac myocytes in rats, an effect mediated by p38 MAP kinase. "Myocardial dysfunction leading to dilated cardiomyopathy has been documented with...

Isolated intraparotid Kaposi sarcoma possible during effective HIV treatment.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Isolated intraparotid KS can develop during effective antiretroviral therapy. According to a study from Greece, "Isolated Kaposi sarcoma (KS) of the parotid gland is an uncommon but distinct entity...

Skin capillary endothelium SDF-1 plays key role in Kaposi sarcoma pathogenesis.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Skin capillary endothelium expression of SDF-1 plays a key role in the pathogenesis of Kaposi sarcoma (KS). According to recent research from the United States, KS, "the most common neoplasm in...

Hepatitis B treatment for HIV patients reviewed.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Current and future options for hepatitis B treatment in HIV patients have been reviewed. "The management of chronic hepatitis B poses specific problems in the presence of human immunodeficiency...

VERSANT HIV drug resistance assay effective.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- The VERSANT HIV drug resistance assay is suitable for clinical use. In a recent study, scientists "evaluated the performance of the VERSANT HIV-1 Resistance Assays (LiPA) in detecting drug...

P. jiroveci DHPS mutations not linked to sulfa drugs in Portugese patients.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Pneumocystis jiroveci DHPS mutations are not linked to sulfa drug therapy in Portugese patients. Scientists in Portugal conducted a study "to evaluate the frequency of mutations of the P. jiroveci...

Alveolar macrophage killing of P. carinii depends on Dectin-1 beta-glucan receptor.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Alveolar macrophage-mediated killing of P. carinii depends on the Dectin-1 beta-glucan receptor. According to scientists in the United States, "Innate immune mechanisms against Pneumocystis...

HIV Nef induces DC differentiation through Vav signaling.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- HIV Nef induces DC differentiation through Vav-mediated signaling. "The accessory HIV-1 Nef protein plays a key role in AIDS pathogenesis," scientists in Italy explained. "We recently...

HIV Nef induces accumulation of MHC II complexes and MVBs.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- The HIV Nef protein induces the accumulation of MHC II complexes and MVBs. "Nef alters the cell surface expression of several immunoreceptors, which may contribute to viral escape," scientists in...

U.S. labor secretary launches HIV/AIDS initiative in Ghana.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- U.S. Secretary of Labor Elaine L. Chao has helped launch the Ghana HIV/AIDS Workplace Education Project as part of a $9.5 million Department of Labor grant to the International Labor Organization (ILO)...

HIV TAT basic peptide has low affinity for VEGF receptor 2.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Contrary to conventional wisdom, the HIV TAT basic peptide has low affinity for VEGF receptor 2. "The 'transactivator of transcription' (TAT) protein of human immunodeficiency virus transforms...

Antibody- and RNA-based HIV testing should be offered to suspected patients.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- HIV testing with both RNA and antibody assays should be available to patients at urban health care centers. According to recent research from the United States, "Acute infection with human...

Antiretroviral treatment increases oxidative stress.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Antiretroviral therapy increases oxidative stress, which underlies both therapeutic benefits and cardiovascular disease risk. "Some diseases and environmental exposures, including those that are...

Early antiretroviral treatment is neuroprotective in vertically infected children.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Early antiretroviral treatment has a neuroprotective effect in children vertically infected with HIV. S. Sanchez-Ramon and colleagues at the University of Madrid "performed a retrospective study...

Imiquimod 5% cream effective against viral warts.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Imiquimod 5% cream is effective against viral warts in HIV patients. "Human immunodeficiency virus (HIV) infects and destroys crucial components of the immune system, leaving patients susceptible...

Nelfinavir-based HAART more durable than indinavir-based treatment.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Nelfinavir-based HAART is more durable than indinavir-based treatment. "The durability of virologic response to antiretroviral therapy is dependent on the potency, tolerability, and adherence level...

Isoniazid effective against latent TB in HIV+ injection drug users.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Isoniazid therapy is effective against latent TB infection in HIV+ injection drug users (IDUs). IDUs "were heavily affected by the tuberculosis (TB) resurgence in New York City in the 1990s,"...

Multiple gene and clade HIV-1 DNA vaccines broaden immune response.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Multiple gene and clade HIV-1 DNA vaccines can broaden the immune response. "The ability to elicit an immune response to a spectrum of human immunodeficiency virus type 1 (HIV-1) gene products from...

WHO: Battle against AIDS will founder without boost to basic healthcare.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Global efforts to battle HIV/AIDS and slash infant mortality rates will founder unless the international community boosts basic medical care in poor countries, the U.N. health agency says. ...

Expanding public insurance for HIV/AIDS could markedly increase survival rates.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- HIV/AIDS patients with public insurance (such as Medicaid) have much lower death rates than those with no insurance, thanks mainly to coverage of lifesaving, yet expensive, antiretroviral drugs, a new...

African Americans are more dissatisfied than whites with healthcare system.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- African American voters are twice as likely as whites to view healthcare as one of the most important issues in deciding how they vote and say that they are more dissatisfied with the U.S. healthcare...

Herpesvirus 8 and Epstein-Barr virus seropositivity among children compared.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Scientists published a comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi sarcoma in a recent issue of the Journal of...

Common variable immunodeficiency may be treatable with B lymphocyte stimulator.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- Some patients with common variable immunodeficiency (CVID) may produce more antibodies, proliferate cells, if stimulated with B lymphocyte stimulator. "B lymphocyte stimulator (BLyS protein) is a...

Shyness can be deadly.
January 12, 2004... 2004 JAN 12 - (NewsRx.com & NewsRx.net) -- How you react to stress influences how easily you resist or succumb to disease, including viruses like HIV, discovered University of California Los Angeles (UCLA) AIDS Institute scientists. ...